PharVision Advisers’s D.R. Horton DHI Stock Holding History

PharVision Advisers’s Portfolio DHI Stock Details DHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,244	Closed	-$211K	–	757
2025 Q3	$211K	Buy	+1,244	New	+$196K	0.12%	471

Other funds holding DHI

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PharVision Advisers's DHI Position: Q4 2025 in Review

PharVision Advisers sold out of D.R. Horton (DHI) in Q4 2025, closing a stake of 1,244 shares — an estimated $211K sold.

PharVision Advisers first reported a position in DHI in Q3 2025 and held it in 1 quarter. The position peaked at $211K in Q3 2025. 1,187 funds tracked by Wall St. Rank hold DHI as of Q4 2025.

PharVision Advisers reported no remaining D.R. Horton position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 1,244 D.R. Horton shares in Q4 2025, an estimated $211K.
PharVision Advisers first reported a position in D.R. Horton in Q3 2025 and held it in 1 quarter.
PharVision Advisers's D.R. Horton position peaked at $211K in Q3 2025.
1,187 funds tracked by Wall St. Rank held D.R. Horton as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.